The Cancer Gene Therapy Market is entering a high-growth phase as advances in genetic engineering, viral-vector technology, cell-based therapies, and precision oncology reshape cancer treatment. The global market was valued at USD 5.8 billion in 2025 and is projected to reach USD 37.5 billion by the end of 2035, expanding at a CAGR of 20.5% during the forecast period from 2026 to 2035. This...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
